Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07047872 · ClinicalTrials.gov registry record · NA

A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction

A NA study of Breast Carcinoma, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07047872: Recruiting NA study of Breast Carcinoma, sponsored by Mayo Clinic.

NCT07047872 is a NA study of Breast Carcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 50 participants, below the 770-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07047872, a NA study of Breast Carcinoma, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This clinical trial evaluates whether a three-dimensional (3D)-printed external breast prosthesis improves patient-reported outcomes (PRO) among breast cancer patients that underwent surgical removal of the breast (mastectomy) without surgical reconstruction. Breast cancer remains a significant health concern and often requires a mastectomy. While breast reconstruction is a common option following a mastectomy, some patients decide not to undergo it or are not candidates. An external breast prosthesis is worn on the outside of the body to replace the breast that was removed during the mastectomy. Traditional external breast prostheses may lack comfort and fit. A 3D-printed external breast prosthesis is customized to the patient using 3D imaging along with computer-aided design (CAD) to interpret the 3D imaging to develop and print a patient-specific external breast prosthesis. This may create a better fitting prosthesis which may improve PRO.

Primary Outcome

Will be assessed by patient self-reported satisfaction with appearance and evaluated descriptively.

Conditions Studied

Interventions

  • OTHER Questionnaire Administration
  • PROCEDURE Computer-Aided Diagnosis
  • PROCEDURE Prosthetics Intervention

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-11-05
Est. Completion 2026-11-05
Phase NA
Mayo Clinic

2,844 total trials

What NCT07047872 shows while recruiting

NCT07047872 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 770-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Breast Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.

NCT07047872 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT07047872 about?

NCT07047872 is a clinical study titled "A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction". This clinical trial evaluates whether a three-dimensional (3D)-printed external breast prosthesis improves patient-reported outcomes (PRO) among breast cancer patients that underwent surgical removal of the breast (mastectomy) without surgical reconstruction. Breast cancer remains a significant heal...

What is the current status of trial NCT07047872?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-11-05. Estimated completion is 2026-11-05.

What conditions does trial NCT07047872 study?

This clinical trial studies the following conditions: Breast Carcinoma.

What interventions are being tested in trial NCT07047872?

The interventions under investigation include: Questionnaire Administration (OTHER), Computer-Aided Diagnosis (PROCEDURE), Prosthetics Intervention (PROCEDURE).

Who is sponsoring clinical trial NCT07047872?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07047872 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07047872's enrollment target sits among peer trials

50 76th of 106 higher than 28 of 106 other Breast Carcinoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07047872, the US trial registry maintained by the National Library of Medicine. NCT07047872 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.